// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

A 10-year review of the magnetic resonance imaging and clinical features of Mayer-Rokitansky-Küster-Hauser syndrome

N.C. Cooper - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparing ultraviolet vaginal ultrasound probe cleaning with a chlorine dioxide wipe system

E. Robinson - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Characteristics of a large cohort of 303 women with unicornuate uterus: subtypes and coexisting gynecological abnormalities

B. Bracco - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Developing a first trimester anomaly screening protocol for the UK: a consensus procedure

J. Karim - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An ultrasound study of the prevalence of endometriosis in pregnancy

E. Bean - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Endometriosis

N/A

Ultrasound examination of the MCDA placenta using low-flow colour Doppler

S. Girardelli - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The risk of pregnancy loss in chorionic villus sampling and amniocentesis in twin pregnancies: a systematic review

S. Saied - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous abortion

N/A

Changes in arterial stiffness among women with twin pregnancies

E. Smith - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Twin–twin transfusion syndrome

N/A

Conservative management of low-risk late fetal growth restriction: an evidence-based management protocol

R.L. Peasley - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Encephalopathy

N/A

Does fetal growth predict low birthweight in suspected late fetal growth restriction?

T. Stampalija - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A new method to predict the risk of growth restriction in fetuses with single umbilical artery

E. Contro - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Maternal and fetal Doppler in uncomplicated term pregnancy in early labour: can we predict small for gestational age at birth?

A. Dall'Asta - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

FSH-secreting pituitary adenoma: a rare cause of ovarian hyperstimulation syndrome

N. Parker - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ovarian hyperstimulation syndrome

Alora

From three-dimensional (3D) ultrasound to 3D shape model of the fetal face: determining a normal reference standard

A.E. Clark - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Assessing the clinical value of fetal MRI for non-CNS abnormalities

R. Tumi - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Ultrasound characteristics, serum biochemistry and outcomes for ectopic pregnancies presenting during the COVID-19 pandemic: retrospective analysis

N.C. Cooper - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Does routine use of ultrasound during evacuation of retained products of conception improve patient outcomes?

A. Calvia - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

In the early first trimester, serum estradiol associates with Lactobacillus dominance in the vaginal niche

H. Fourie - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Alora

The pregnancy outcomes of tubal and ovarian heterotopic pregnancies

S.A. Solangon - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous abortion

N/A

The ability of plasma proteins to predict pregnancy outcome in the first trimester

H. Fourie - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous abortion

N/A

Copyright © 2026. QuantiNova All rights reserved